Patients who were receiving abacavir at study entry had elevated baseline levels of some inflammatory biomarkers. During the course of the study, current abacavir use was associated with higher ...

In a surprising finding from the DAD Study, recent use of abacavir or ddI was associated with increased risk for myocardial infarction. In accompanying correspondence, GSK investigators summarized ...